OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India
Newsroom




- Nov 8, 2022
OnQuality Pharmaceuticals Announces Enrollment of First Patient in Part 2 of the NOVA-II Phase 2


- Oct 13, 2022
OnQuality Pharmaceuticals to Present Two Posters at the 34th EORTC-NCI-AACR Symposium


- May 27, 2022
OnQuality Pharmaceuticals to Have Two Abstracts Published in the 2022 ASCO Annual Meeting Proceeding


- Mar 8, 2022
OnQuality Pharmaceuticals to Present Preclinical Data for OQL051, a Novel CID Therapeutic, at AACR


- Feb 14, 2022
OnQuality Pharmaceuticals to Present NOVA-II Phase 2 Trial Update and Oncologist Survey at ASCO GU

![OnQuality Pharmaceuticals to Present Oncologist Survey Data Demonstrating Need for [...]](https://static.wixstatic.com/media/a4ef6a_7c5bd05812f94423a3d7687030b5a11c~mv2.jpg/v1/fill/w_291,h_219,fp_0.50_0.50,q_90,enc_auto/a4ef6a_7c5bd05812f94423a3d7687030b5a11c~mv2.jpg)
- Jan 19, 2022
OnQuality Pharmaceuticals to Present Oncologist Survey Data Demonstrating Need for [...]

![OnQuality Pharmaceuticals Reports Topline Data from Phase 2 Trial of Treatment for Cancer [...]](https://static.wixstatic.com/media/a4ef6a_7c5bd05812f94423a3d7687030b5a11c~mv2.jpg/v1/fill/w_291,h_219,fp_0.50_0.50,q_90,enc_auto/a4ef6a_7c5bd05812f94423a3d7687030b5a11c~mv2.jpg)
- Jan 4, 2022
OnQuality Pharmaceuticals Reports Topline Data from Phase 2 Trial of Treatment for Cancer [...]


- Sep 7, 2021
OnQuality Pharmaceuticals Announces Completion of Part 1 of NOVA-II Trial


- Jun 9, 2021
OnQuality Pharmaceuticals Announces Upcoming Presentation at 2021 BIO Digital